Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia-Reference-Cited by-同舟云学术

Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia

Published:2020-06-02 Issue:11 Volume:34 Page:2898-2902
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Wander Priscilla,Cheung Laurence C.^ORCID,Pinhanҫos Sandra S.,Jones Luke,Kerstjens Mark,Arentsen-Peters Susan T.C.J.M.,Singh Sajla,Chua Grace-Alyssa,Castro Patricia Garrido,Schneider Pauline^ORCID,Dolman M. Emmy M.,Koopmans Bianca,Molenaar Jan J.,Pieters Rob,Zwaan C. Michel,Kotecha Rishi S.^ORCID,Stam Ronald W.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/s41375-020-0895-9.pdf

Reference15 articles.

1. Hunger SP, Mullighan CG. Acute lymphoblastic leukemia in children. N Engl J Med. 2015;373:1541–52.

2. Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet. 2007;370:240–50.

3. Stam RW, Schneider P, Hagelstein JA, van der Linden MH, Stumpel DJ, de Menezes RX, et al. Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood. 2010;115:2835–44.

4. Agraz-Doblas A, Bueno C, Bashford-Rogers R, Roy A, Schneider P, Bardini M, et al. Unravelling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. Haematologica. 2019;104:1176–88.

5. Pieters R, den Boer ML, Durian M, Janka G, Schmiegelow K, Kaspers GJ, et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia-implications for treatment of infants. Leukemia. 1998;12:1344–8.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical efficacy of azacitidine and venetoclax for infant KMT2A-rearranged acute lymphoblastic leukemia reveals a new therapeutic strategy;Leukemia;2022-11-15

2. Molecular Characterization of the Response to Conventional Chemotherapeutics in Pro-B-ALL Cell Lines in Terms of Tumor Relapse;Genes;2022-07-14

3. Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia;Frontiers in Oncology;2022-01-20

4. Preclinical efficacy of prexasertib in acute lymphoblastic leukemia;British Journal of Haematology;2021-06-07